COMPANY PROFILE

Rona Therapeutics

Explore full profile

RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines

Huangpu, ChinaFounded 2021Biotech & Life Sciences

Valuation $100–250M Last recorded · 2025

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Rona Therapeutics

Rona Therapeutics is a cutting-edge company specializing in RNA therapeutics, focusing on the discovery and development of modular and programmable RNA medicines. The company serves patients worldwide, leveraging its deep expertise in RNA therapeutics and collaboration with leading scientific advisors. Operating in the biotechnology and pharmaceutical markets, Rona Therapeutics targets diseases such as kidney and liver disorders through innovative RNA editing and oligonucleotide-based therapies. The business model revolves around research and development, strategic partnerships, and global licensing deals, such as their recent agreement with Sanofi. Revenue is generated through licensing fees, milestone payments, and potential royalties from successful therapies. The company recently completed its Series A financing, underscoring investor confidence in its innovative approach and market potential.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: Huangpu, China
Employees: 19
Open positions: None listed
Dealroom signal: 79.1/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VCOther financing	Mar 2025	$25M	$100M	Lilly Asia Ventures · BioTrack Capital · LongRiver Investments · Guanghua Kaiyuan Capital	↗
SERIES AOther financing	Jul 2024	$35M	$140M	Lilly Asia Ventures · BioTrack Capital · Zhongqi Private Equity Fund Management (Hainan) · LongRiver Investments	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Rona Therapeutics website traffic

Latest recorded traffic for Rona Therapeutics is 1.1K monthly website visits, down 35.3% over the last three months. Rona Therapeutics's team grew 11.8% over the past year.

Latest monthly visits1.1K 3-month web change-35.3% 1-year team growth+11.8%

Monthly website visitsDec 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
INInnoVeinInnoVein is revolutionizing vein care with an implantable valve	San Carlos, United States	Closed	2	$11M	$10M
GBGOGO BANDA medical devices company pioneering the use of biometric data from wearables using AI/ML predictive analytics to manage chronic health conditions	Ashland, United States	Operational
CECellSineProvides devices and software that make advanced electrochemical impedance spectroscopy easily accessible to any microbiological researcher	Etterbeek, Belgium	Operational
IBInterAx BiotechDelivering High-Quality Drug Candidates for GPCR Targets	Villigen, Switzerland	Operational
SYSynyiThe leading medical artificial intelligence company focusing on medical data governance, mining, and application	Pudong, China	Operational
OUOutsenseOutSense has developed a novel technology capable of accurately analyzing and diagnosing human waste from within a standard toilet bowl	Or Yehuda, Israel	Operational
MTMedivie TherapeuticThe world's leading manufacturer of customized dental protectors	Tel Aviv-Yafo, Israel	Operational
SOSDS OpticFirst ever European based cutting-edge medical DeepTech connecting molecular biology with novel photonics technologies, chemistry & biomedical engineering	Lublin, Poland	Operational